Group 1 - Amgen will present at the Goldman Sachs 46th Annual Global Healthcare Conference on June 10, 2025, at 9:20 a.m. PT, featuring executives Peter Griffith and Jay Bradner [1] - The webcast of the presentation will be available on Amgen's website and archived for at least 90 days [2] - Amgen is recognized for its innovative medicines and has a strong pipeline targeting various diseases, including cancer and heart disease [3] Group 2 - In 2024, Amgen received accolades such as being named one of the "World's Most Innovative Companies" and "America's Best Large Employers" [4] - Amgen is part of the Dow Jones Industrial Average and the Nasdaq-100 Index, highlighting its market significance [4]

Company Overview - Amgen is a biotechnology company that discovers, develops, manufactures, and delivers innovative medicines to combat serious diseases [3] - The company has a broad and deep pipeline aimed at treating cancer, heart disease, osteoporosis, inflammatory diseases, and rare diseases [3] - Amgen has been recognized as one of the "World's Most Innovative Companies" by Fast Company and one of "America's Best Large Employers" by Forbes in 2024 [4] Upcoming Events - Amgen will present at the Jefferies Global Healthcare Conference on June 4, 2025, at 9:20 a.m. ET [1] - The presentation will be made by Peter Griffith, CFO, and Murdo Gordon, EVP of Global Commercial Operations [1] - The webcast of the presentation will be available for replay for at least 90 days after the event [2]

Company Overview - Amgen is a biotechnology company that discovers, develops, manufactures, and delivers innovative medicines to combat serious diseases [3] - The company has a broad and deep pipeline focused on treating cancer, heart disease, osteoporosis, inflammatory diseases, and rare diseases [3] - Amgen has been recognized as one of the "World's Most Innovative Companies" by Fast Company and one of "America's Best Large Employers" by Forbes in 2024 [4] Upcoming Events - Amgen will present at the 2025 RBC Capital Markets Global Healthcare Conference on May 21, 2025, at 9:00 a.m. ET [1] - Kave Niksefat, senior vice president of Global Marketing and Access, will be the presenter at the conference [1] - The presentation will be available via a webcast, which will also be archived for at least 90 days after the event [2]

Core Viewpoint - Amgen is set to report its first quarter 2025 financial results on May 1, 2025, followed by a conference call with senior management [1] Group 1: Financial Reporting - Amgen will announce its Q1 2025 financial results after the close of U.S. financial markets on May 1, 2025 [1] - A conference call will take place at 4:30 p.m. ET, featuring CEO Robert A. Bradway and other senior management members [1] Group 2: Conference Call Details - The conference call will be broadcast live over the internet, accessible to media, investors, and the general public [2] - The webcast will be archived for at least 90 days for replay [3] Group 3: Company Overview - Amgen is a leader in biotechnology, focusing on innovative medicines for serious diseases, with over 40 years of industry experience [4] - The company has a diverse pipeline targeting cancer, heart disease, osteoporosis, inflammatory diseases, and rare diseases [4] Group 4: Recognition and Index Inclusion - In 2024, Amgen was recognized as one of the "World's Most Innovative Companies" by Fast Company and one of "America's Best Large Employers" by Forbes [5] - Amgen is part of the Dow Jones Industrial Average and the Nasdaq-100 Index, highlighting its market capitalization and innovation [5]